Treatment of psoriasis with 6-thioguanine and hepatic venoocclusive disease.
Romagosa
Ricardo
R
Kerdel
Francisco
F
Shah
Neha
N
D001707:Biopsy, Needle; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006504:Hepatic Veno-Occlusive Disease / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D008111:Liver Function Tests; D008875:Middle Aged; D011565:Psoriasis / Q000175:diagnosis / Q000188:drug therapy*; D018570:Risk Assessment; D012720:Severity of Illness Index; D013866:Thioguanine / Q000008:administration & dosage / Q000009:adverse effects*
D013866:Thioguanine